AN
Afreen Naaz Qadir Khan
About Afreen Naaz Qadir Khan
Data last updated:
Afreen Naaz Qadir Khan is a Director at Amethealth Care Private Limited (since 2016) and Director at Epiderme Laboratories Private Limited (since 2022). The companies operate in Consumer Goods and Non-Profit Organizations. The largest current company by reported revenue is Amethealth Care Private Limited at ₹1.78 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 16 Aug 2016 | 2016 | ₹1.78 Cr (FY 2025) | Active | |
| Director | 17 Aug 2022 | 2022 | Active |
Board colleagues of Afreen Naaz Qadir Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Qadir Gaffar Khan | 06601735 | Amethealth Care Private Limited , Epiderme Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Afreen Naaz Qadir Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Afreen Naaz Qadir Khan
Afreen Naaz Qadir Khan currently holds 2 directorships: Amethealth Care Private Limited (Director, since 16 Aug 2016, revenue ₹1.78 Cr (FY 2025)); Epiderme Laboratories Private Limited (Director, since 17 Aug 2022).
Afreen Naaz Qadir Khan was first appointed on 16 Aug 2016 as Director at Amethealth Care Private Limited. The most recent appointment on record is 17 Aug 2022 at Epiderme Laboratories Private Limited.
The current boards of Afreen Naaz Qadir Khan's companies include Qadir Gaffar Khan (Amethealth Care Private Limited).